Bimodal expression of RHOH during myelomonocytic differentiation: Implications for the expansion of AML differentiation therapy.

Autor: Galiègue‐Zouitina, Sylvie, Fu, Qiangwei, Carton‐Latreche, Céline, Poret, Nicolas, Cheok, Meyling, Leprêtre, Frédéric, Figeac, Martin, Quesnel, Bruno, El Bouazzati, Hassiba, Shelley, Carl S

Publikováno v: EJHaem; May2021, Vol. 2 Issue 2, p196-210, 15p

Incidence of ATRX mutations in myelodysplastic syndromes, the value of microcytosis

Autor: Herbaux, Charles, Duployez, Nicolas, Badens, Catherine, Poret, Nicolas, Gardin, Claude, Decamp, Mathieu, Eclache, Virginie, Daliphard, Sylvie, Murati, Anne, Cony-Makhoul, Pascale, Cheze, Stéphane, Beve, Blandine, Lacoste, Caroline, Prebet, Thomas, Hunault-Berger, Mathilde, Maloisel, Frédéric, Renneville, Aline, Figeac, Martin, Stamatoullas-Bastard, Aspasia, Bastard, Christian, Fenaux, Pierre, Preudhomme, Claude, Rose, Christian

Publikováno v: American Journal of Hematology
American Journal of Hematology, 2015, 90 (8), pp.737-738. ⟨10.1002/ajh.24073⟩
American Journal of Hematology, Wiley, 2015, 90 (8), pp.737-738. ⟨10.1002/ajh.24073⟩

International audience; Acquired α-thalassemia myelodysplastic syndrome (MDS) (ATMDS) is an acquired syndrome characterized by a somatic point mutation or splicing defect in the ATRX gene in patients with myeloid disorders, primarily MDS. In a large

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3fc690abedbd34cd8a8895f7ea6d782b
https://pubmed.ncbi.nlm.nih.gov/26017030

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

B-Cell-Specific Transcription Factor BACH2 Involved in the Clinical Behavior Heterogeneity of Waldenström Macroglobulinemia

Autor: Herbaux, Charles ^*, Marot, Guillemette ^*, Bertrand, Elisabeth ^*, Broucqsault, Natacha ^*, Zouitna-Galiègue, Sylvie ^*, Roumier, Christophe ^*, Poret, Nicolas ^*, Soenen, Valérie ^*, Nibourel, Olivier ^*, Roche-Lestienne, Catherine ^*, Renneville, Aline ^*, Boyle, Eileen ^*, Fouquet, Guillemette ^*, Tricot, Sabine ^*, Preudhomme, Claude ^*, Quesnel, Bruno, Poulain, Stephanie ^*, Leleu, Xavier

Publikováno v: In Blood 16 November 2012 120(21):1288-1288

BACH2 promotes indolent clinical presentation in Waldenström macroglobulinemia.

Autor: Herbaux C; Inserm U837, Team 3, Cancer Research Institute of Lille, Lille, France.; Service des Maladies du Sang, Hôpital Huriez, CHRU, Lille, France., Bertrand E; Inserm U837, Team 3, Cancer Research Institute of Lille, Lille, France., Marot G; Lille Nord de France University, Equipe Biostatistique, UDSL, Lille, France., Roumier C; Laboratory d'Hématologie, Biologie and Pathologie Center, CHRU, Lille, France., Poret N; Inserm U837, Team 3, Cancer Research Institute of Lille, Lille, France., Soenen V; Laboratory d'Hématologie, Biologie and Pathologie Center, CHRU, Lille, France., Nibourel O; Laboratory d'Hématologie, Biologie and Pathologie Center, CHRU, Lille, France., Roche-Lestienne C; Laboratory d'Hématologie, Biologie and Pathologie Center, CHRU, Lille, France., Broucqsault N; Inserm U837, Team 3, Cancer Research Institute of Lille, Lille, France., Galiègue-Zouitina S; Inserm U837, Team 3, Cancer Research Institute of Lille, Lille, France., Boyle EM; Service des Maladies du Sang, Hôpital Huriez, CHRU, Lille, France., Fouquet G; Service des Maladies du Sang, Hôpital Huriez, CHRU, Lille, France., Renneville A; Laboratory d'Hématologie, Biologie and Pathologie Center, CHRU, Lille, France., Tricot S; Département d'Hématologie-Immunologie-Cytogénétique, CH, Valenciennes, France., Morschhauser F; Service des Maladies du Sang, Hôpital Huriez, CHRU, Lille, France., Preudhomme C; Laboratory d'Hématologie, Biologie and Pathologie Center, CHRU, Lille, France., Quesnel B; Inserm U837, Team 3, Cancer Research Institute of Lille, Lille, France.; Service des Maladies du Sang, Hôpital Huriez, CHRU, Lille, France., Poulain S; Département d'Hématologie-Immunologie-Cytogénétique, CH, Valenciennes, France., Leleu X; Service d'Hématolgie et Thérapie cellulaire, Hématologie, CHU, Poitiers, France.; Centre d'Investigation Clinique Inserm, CHU, Poitiers, France.

Publikováno v: Oncotarget [Oncotarget] 2016 Jun 07; Vol. 8 (34), pp. 57451-57459. Date of Electronic Publication: 2016 Jun 07 (Print Publication: 2017).